Skip to main content
Clinical Trials/DRKS00000612
DRKS00000612
Completed
N/A

An assessment of the potential clinical utility of a new multiplex-PCR assay (VYOO®) in the management of ICU patients with sepsis - KS-2009-028 VYOO-MultiSep

SIRS-Lab GmbH0 sites1,050 target enrollmentJanuary 7, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
SIRS-Lab GmbH
Enrollment
1050
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 7, 2011
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
SIRS-Lab GmbH

Eligibility Criteria

Inclusion Criteria

  • Signed Informed Consent Form by the patient or their legal representative
  • \- All adult (age \= 18\) patients with suspicion of sepsis, severe sepsis or septic shock (ACCP/SCCM criteria) and indication for blood culture (defined according to Expertengremium Mikrobiologisch\-infektiologische Qualitätsstandard” (MiQ 3 a 2007\)

Exclusion Criteria

  • \- The additional blood sampling of 10ml (2 x 5 ml) for VYOO® testing is not advisable for medical reasons
  • \- Less than two sets of blood cultures could be taken
  • \- Absolute neutrophil count is less than 1’500 / µl blood

Outcomes

Primary Outcomes

Not specified

Similar Trials